These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32764910)

  • 1. Estimation of the Clinical and Economic Impact of an Improvement in Adherence Based on the Use of Once-Daily Single-Inhaler Triple Therapy in Patients with COPD.
    Miravitlles M; Marín A; Huerta A; Carcedo D; Villacampa A; Puig-Junoy J
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1643-1654. PubMed ID: 32764910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Characteristics, Treatment Persistence, and Outcomes Among Patients With COPD Treated With Single- or Multiple-Inhaler Triple Therapy: A Retrospective Analysis in Spain.
    Alcázar-Navarrete B; Jamart L; Sánchez-Covisa J; Juárez M; Graefenhain R; Sicras-Mainar A
    Chest; 2022 Nov; 162(5):1017-1029. PubMed ID: 35787391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of treatment persistence, adherence, and risk of exacerbation in patients with COPD treated with single-inhaler
    Lin L; Liu C; Cheng W; Song Q; Zeng Y; Li X; Deng D; Liu D; Chen Y; Cai S; Chen P
    Front Pharmacol; 2023; 14():1147985. PubMed ID: 37025493
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting.
    Halpin DMG; Rothnie KJ; Banks V; Czira A; Compton C; Wood R; Tritton T; Massey O; Wild R; Snowise N; Nikitin K; Sharma R; Ismaila AS; Vogelmeier CF
    Int J Chron Obstruct Pulmon Dis; 2022; 17():2417-2429. PubMed ID: 36185170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness Analysis of a Once-Daily Single-Inhaler Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease (COPD) Using the FULFIL Trial: A Spanish Perspective.
    Schroeder M; Benjamin N; Atienza L; Biswas C; Martin A; Whalen JD; Izquierdo Alonso JL; Riesco Miranda JA; Soler-Cataluña JJ; Huerta A; Ismaila AS
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1621-1632. PubMed ID: 32764908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT Trial.
    Ismaila AS; Risebrough N; Schroeder M; Shah D; Martin A; Goodall EC; Ndirangu K; Criner G; Dransfield M; Halpin DM; Han MK; Lomas DA
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2681-2695. PubMed ID: 31819401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic impact of delaying initiation with multiple-inhaler maintenance triple therapy in Spanish patients with chronic obstructive pulmonary disease.
    Sicras Mainar A; Huerta A; Navarro Artieda R; Monsó E; Landis SH; Ismaila AS
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2121-2129. PubMed ID: 31571848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When to use single-inhaler triple therapy in COPD: a practical approach for primary care health care professionals.
    Gaduzo S; McGovern V; Roberts J; Scullion JE; Singh D
    Int J Chron Obstruct Pulmon Dis; 2019; 14():391-401. PubMed ID: 30863039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying the Economic Impact of Delayed Multiple-Inhaler Triple Therapy Initiation in Patients with COPD: A Retrospective Cohort Study of Linked Electronic Medical Record and Hospital Administrative Data in England.
    Sansbury LB; Wood RP; Anley GA; Nam Y; Ismaila AS
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2795-2808. PubMed ID: 34675504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Single Combination Inhaler versus Multiple Inhalers to Deliver the Same Medications for Patients with Asthma or COPD: A Systematic Literature Review.
    Zhang S; King D; Rosen VM; Ismaila AS
    Int J Chron Obstruct Pulmon Dis; 2020; 15():417-438. PubMed ID: 32161454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD.
    Bourbeau J; Bafadhel M; Barnes NC; Compton C; Di Boscio V; Lipson DA; Jones PW; Martin N; Weiss G; Halpin DMG
    Int J Chron Obstruct Pulmon Dis; 2021; 16():499-517. PubMed ID: 33688176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PROMETHEUS: Long-Term Exacerbation and Mortality Benefits of Implementing Single-Inhaler Triple Therapy in the US COPD Population.
    Criner G; Martinez F; Gandhi H; Pyenson B; Feigler N; Emery M; Gupta U; Vaduganathan M
    J Health Econ Outcomes Res; 2023; 10(1):20-27. PubMed ID: 36742194
    [No Abstract]   [Full Text] [Related]  

  • 13. Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trials.
    Ferguson GT; Brown N; Compton C; Corbridge TC; Dorais K; Fogarty C; Harvey C; Kaisermann MC; Lipson DA; Martin N; Sciurba F; Stiegler M; Zhu CQ; Bernstein D
    Respir Res; 2020 May; 21(1):131. PubMed ID: 32471423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of single-inhaler triple therapy for patients with severe COPD: a systematic literature review.
    Rana RH; Alam K; Keramat SA; Gow J
    Expert Rev Respir Med; 2022 Oct; 16(10):1067-1084. PubMed ID: 36350733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The IMPACT Study - Single Inhaler Triple Therapy (FF/UMEC/VI) Versus FF/VI And UMEC/VI In Patients With COPD: Efficacy And Safety In A Japanese Population.
    Kato M; Tomii K; Hashimoto K; Nezu Y; Ishii T; Jones CE; Kilbride S; Gross AS; Clifton CS; Lipson DA
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2849-2861. PubMed ID: 31839705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of single inhaler triple therapy vs single inhaler dual therapy or separate triple therapy for the management of chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized controlled trials.
    Lai CC; Chen CH; Lin CYH; Wang CY; Wang YH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1539-1548. PubMed ID: 31371939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exacerbations and health care resource use among patients with COPD in relation to blood eosinophil counts.
    Müllerová H; Hahn B; Simard EP; Mu G; Hatipoğlu U
    Int J Chron Obstruct Pulmon Dis; 2019; 14():683-692. PubMed ID: 30962682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential clinical and economic impact of optimised maintenance therapy on discharged patients with COPD after hospitalisation for an exacerbation in China.
    Salem A; Zhong H; Ramos M; Lamotte M; Hu H
    BMJ Open; 2021 Apr; 11(4):e043664. PubMed ID: 33910947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalising adherence-enhancing interventions using a smart inhaler in patients with COPD: an exploratory cost-effectiveness analysis.
    van Boven JFM; Cushen B; Sulaiman I; Greene G; MacHale E; Mokoka MC; Doyle F; Reilly RB; Bennett K; Costello RW
    NPJ Prim Care Respir Med; 2018 Jun; 28(1):24. PubMed ID: 29950601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving inhaler adherence in patients with chronic obstructive pulmonary disease: a cost-effectiveness analysis.
    van Boven JF; Tommelein E; Boussery K; Mehuys E; Vegter S; Brusselle GG; Rutten-van Mölken MP; Postma MJ
    Respir Res; 2014 Jun; 15(1):66. PubMed ID: 24929799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.